Hackensack Meridian Health — Carrier Clinic
Donald Parker is President of Hackensack Meridian Health – Carrier Clinic. Prior to joining Carrier Clinic in 2013, Donald served as the Vice President for Physician Services and Ambulatory Care at St. Joseph’s Health System. Previously, Parker was appointed as President/ CEO of Atlantic Mental Health for 15 years and subsequently merged into the AtlantiCare Health System. At AtlantiCare, he served in multiple leadership roles, including V.P. of Business Development and President of AtlantiCare Health Services, where he developed and provided leadership to over twenty ambulatory businesses with forty-two locations. Parker’s capstone accomplishment at AtlantiCare was his participation on the Leadership Team of the Health System as it earned and was awarded the Malcolm Baldrige Award, a Presidential recognition for quality and achievement. He was also the Chief Operating Officer and a Partner for a Health Care Consulting firm, Carlisle and Associates. A Licensed Clinical Social Worker who completed his Master’s Degree at Rutgers, Parker provides leadership in many civic and volunteer organizations as well. Don has served on numerous public and private boards, including public and college school boards, chairing New Jersey’s Association of Mental Health Centers for two terms, being a founding member and chair of Gilda’s Club of South Jersey, and chaired a New Jersey Supreme Court Committee responsible for rewriting divorce regulations for the State. He was recently honored by the Boy Scouts of America with The Toast of Scouting Award, presented for outstanding community service and leadership. He currently serves as a board member on The National Association of Psychiatric Health Systems, New Jersey Hospital Association, and the Somerset County Business Partnership and the Atlantic Cape Community College Board of Trustees.
DAY 1 PM WORKSHOP
Emerging Use of Genetics in Successfully Preventing & Treating Opioid Use Disorders
Clinicians understand there is a genetic link to the development of Substance Use Disorders in that family history is present in upwards of 60% of those treated, even when ruling our environmental factors. Medical studies are increasingly able to identify genetic markers that indicate greater susceptibility to development of SUD’s. Increasingly, protocols are being developed to identify and target (through genetic testing) the unique ‘gene sequence’ of an individual in order to treat the identifiers associated with higher risk of developing SUD’s, thus mitigating the significant genetic risk factors.
This workshop will explore:
Challenges related to the battle against opiate misuse, the opiate epidemic, and treatment protocols for opiate use disorders
The latest industry practices, including research into the role of genetics in preventing and treating Opiate Use Disorders
Emerging urgent care services in addiction and behavioral health
This workshop is approved for 1-hour Renewal Credit/CEU for: IC&RC/NJ-AP Certification Board | NAADAC | and DOE.